Companies make progress tackling drug-resistant infections, foundation says

"Drugmakers have made some progress in restraining antibiotics overuse, which leads to drug-resistant infections, but have fallen short in making antibiotics more widely available in low-income countries, an influential foundation said," Reuters reports. 

"For the third time since 2018 and 2020, the non-profit Access to Medicine Foundation (AMF) has analysed how companies are dealing with the two-pronged challenge of making bacteria-fighting drugs more widely available in poor countries while also reining in the type of excess use that is known to foster superbugs."

The article has been picked up by a number of publications around the world, including The Wire Science, Euronews.com, and The India Times.

Click to read the full Reuters article.